| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 08/25/2009 | US7579439 Modulation of IL-2- and IL-15-mediated T cell responses |
| 08/25/2009 | US7579432 Cyclic peptides as G-protein-coupled receptor antagonists |
| 08/25/2009 | US7579362 3-(6-p-Tolyl-pyridin-3-yloxy)-1-aza-bicyclo[2.2.2]octane; treatment of psychotic disorders such as schizophrenia, mania, depression and anxiety; neurodegenerataive disorders such as senile dementia, Alzhelmer's disease and other intellectual impairment disorders |
| 08/25/2009 | US7579347 Vanilloid receptor ligands and their use in treatments |
| 08/25/2009 | US7579342 Pteridine compounds for the treatment of psoriasis |
| 08/25/2009 | US7579186 Human monoclonal antibody against TGF-β type II receptor and medicinal use thereof |
| 08/25/2009 | US7579023 Method of preparation and composition of a water soluble extract of the bioactive component of the plant species Uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals |
| 08/25/2009 | US7579001 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| 08/25/2009 | CA2439078C Composition improving age-related physiological deficits and increasing longevity |
| 08/25/2009 | CA2395539C Soluble interleukin-20 receptor |
| 08/25/2009 | CA2375671C 4-phenyl-pyrimidine derivatives |
| 08/25/2009 | CA2366932C Cyclic protein tyrosine kinase inhibitors |
| 08/25/2009 | CA2269246C Substituted tricyclics |
| 08/25/2009 | CA2099541C Cyclic adhesion inhibitors |
| 08/20/2009 | WO2009102893A2 CYCLIC DIARYL ETHER COMPOUNDS AS ANTAGONISTS OF PROSTAGLANDIN D2 receptors |
| 08/20/2009 | WO2009102191A1 Health supplement composition of sea cucumber |
| 08/20/2009 | WO2009101917A1 Bicycloamine derivative |
| 08/20/2009 | WO2009101856A1 Remedy for rheumatoid arthritis |
| 08/20/2009 | WO2009100530A1 Uses of modified elr-cxc chemokine g31p |
| 08/20/2009 | WO2009082641A3 Compositions and methods for treating diseases associated with angiogenesis and inflammation |
| 08/20/2009 | WO2009071905A3 Use of thiolatocobalamins as regulators/selective promoters of inducible and constitutive nitric oxide synthases |
| 08/20/2009 | WO2009046872A3 Use of a peptide as a therapeutic agent |
| 08/20/2009 | WO2009033808A3 Use of a peptide as a therapeutic agent |
| 08/20/2009 | WO2009012156A3 Treatments and diagnostics for cancer, inflammatory disorders and autoimmune disorders |
| 08/20/2009 | US20090209655 Isoflavone metabolites |
| 08/20/2009 | US20090209648 Phenylacetic Acid Derivatives |
| 08/20/2009 | US20090209610 Polymorphic form of 6-(4-chlorophenyl)-2,2-dimethyl-7-Phenyl-2,3-Dihydro-1h-Pyrrolizin-5-Ylacetic Acid |
| 08/20/2009 | US20090209596 Oxazole Hydroxamic Acid Derivatives and Use Thereof |
| 08/20/2009 | US20090209595 Method of treating of demyelinating diseases or conditions |
| 08/20/2009 | US20090209594 Method of treating of demyelinating diseases or conditions |
| 08/20/2009 | US20090209571 Phenanthrene derivatives as MPGES-1 inhibitors |
| 08/20/2009 | US20090209570 6-Aminomorphinane Derivatives, Method for the Production and Use Thereof |
| 08/20/2009 | US20090209559 Pharmaceutical compounds |
| 08/20/2009 | US20090209555 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial |
| 08/20/2009 | US20090209540 Novel Biaryl Benzolmidazole Derivatives and Pharmaceutical Composition Comprising The Same |
| 08/20/2009 | US20090209523 Pyrrolo[1,2-A] Pyrazin-1(2H)-One and Pyrrolo[1,2-D][1,2,4]Triazin-1(2H)-One Derivatives as Inhibitors of Poly(Adp-Ribose)Polymerase (Parp) |
| 08/20/2009 | US20090209514 Tetrahydro-Naphthalene Derivatives as Vanilloid Receptor Antagonists |
| 08/20/2009 | US20090209477 Azacytidine analogues and uses thereof |
| 08/20/2009 | US20090209458 Cell-penetrating socs polypeptides that inhibit cytokine-induced signaling |
| 08/20/2009 | US20090208513 Diagnostic And Therapeutic Uses Of Augmenter Of Liver Regeneration In Inflammatory Conditions |
| 08/20/2009 | US20090208504 Polypeptides involved in immune response |
| 08/20/2009 | US20090208481 Proteomic analysis of active multiple sclerosis lesions |
| 08/20/2009 | US20090208424 Compositions and methods for delivery of solution to the skin |
| 08/20/2009 | US20090208416 Monoclonal antibodies against nkg2a |
| 08/20/2009 | CA2747133A1 Uses of modified elr-cxc chemokine g31p |
| 08/20/2009 | CA2714591A1 Bicycloamine derivative |
| 08/20/2009 | CA2689680A1 Fc receptor-binding polypeptides with modified effector functions |
| 08/19/2009 | EP2090589A1 Albumin-fused Kunitz domain peptides |
| 08/19/2009 | EP2090583A1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 08/19/2009 | EP2090571A1 Pyrimidine derivates, medicaments comprising them, their use and process of their preparation |
| 08/19/2009 | EP2090334A2 Imidazole based compounds, compositions comprising them and methods of their use |
| 08/19/2009 | EP2090311A1 Use of compounds binding to the sigma receptor ligands for the treatment of neuropathic pain developing as a consequence of chemotherapy |
| 08/19/2009 | EP2090304A2 Use of sugar phosphates, sugar phosphate analogues, amino acids and/or amino acid analogues for modulating the glycose-enzyme complex, the malate aspartate shuttle and/or transaminases |
| 08/19/2009 | EP2090177A1 Food products having enhanced cocoa polyphenol content |
| 08/19/2009 | EP2089521A1 Soluble tnf receptors and their use in treatment of disease |
| 08/19/2009 | EP2089389A2 Heterocyclic compounds as modulators of glucocorticoid receptor, ap-1, and/or nf-kappa-b activity |
| 08/19/2009 | EP2089383A1 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
| 08/19/2009 | EP2089350A1 Crystalline potassium salt of lipoxin a4 analogs |
| 08/19/2009 | EP2089023A2 Methods of treating neuropathic pain with agonists of ppar-gamma |
| 08/19/2009 | EP2089013A1 Acetaminophen / ibuprofen combinations |
| 08/19/2009 | EP1971369B1 Combination of r,r-glycopyrrolate, rolipram and budesonide for the treatment of inflammatory diseases |
| 08/19/2009 | EP1635824B1 5-membered heterocycle-based p-38 inhibitors |
| 08/19/2009 | EP1628987B1 Mannose-6-phosphonate compounds for the treatment of inflammatory diseases |
| 08/19/2009 | EP1569672B1 Use of a centella asiatica extract rich in madecassoside and in terminoloside |
| 08/19/2009 | EP1485393B1 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives |
| 08/19/2009 | EP1482973B1 Methods of modulating cd200 receptors |
| 08/19/2009 | EP1465593B1 Solid orally-dispersible pharmaceutical formulation |
| 08/19/2009 | EP1463498B1 pharmaceutical COMPOSITION comprising a catechin, ascorbic acid, proline and lysine FOR THE TREATMENT OF NEOPLASTIC DISEASES |
| 08/19/2009 | EP1414466B1 Combinations for the treatment of inflammatory disorders |
| 08/19/2009 | EP1255829B1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/19/2009 | EP1194167B1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 08/19/2009 | CN101511852A Synthesis of diethyl{ i5'' (3 -fluorophenyl) -pyridine-2-yl] methyl} phosphonate used in the synthesis of himbacine analogs |
| 08/19/2009 | CN101511831A Adenosine derivatives as A2A receptor agonists. |
| 08/19/2009 | CN101511828A Heteroaryl derivatives as protein kinase inhibitors |
| 08/19/2009 | CN101511819A N-(aminoheteroaryl)-1H-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 08/19/2009 | CN101511809A 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 08/19/2009 | CN101511800A Triazolyl phenyl benzenesulfonamides |
| 08/19/2009 | CN101511797A Benzimidazole modulators of VR1 |
| 08/19/2009 | CN101511787A Substituted N-phenylmethyl -5-oxo-proline-2-amides as P2X7-receptor antagonists and their methods of use |
| 08/19/2009 | CN101511378A Nouvel extrait d'eucalyptus, son procede de preparation et ses utilisations therapeutiques |
| 08/19/2009 | CN101511350A Dioxo-alkanes and dioxo-alkenes |
| 08/19/2009 | CN101508689A Synthesis of oroxylin |
| 08/19/2009 | CN101507819A Large-grainsize medicine intercalated hydrotalcite and preparation method thereof |
| 08/19/2009 | CN101507818A Capsaicin beta-cyclodectrin inclusion-compound and liposome and gel of inclusion-compound |
| 08/19/2009 | CN101507806A Sticking plaster capable of treating rheumathritis, hyperosteogeny, neck, shoulder, lumbar disease ache |
| 08/19/2009 | CN101507804A Medicine for injury pain and its preparation technique |
| 08/19/2009 | CN101507802A Medicine for treating ankylosing spondylitis |
| 08/19/2009 | CN101507768A Qiwei dan capable of treating arthralgia due to wind cold dampness |
| 08/19/2009 | CN101507758A Traditional Chinese medicine combination |
| 08/19/2009 | CN101507755A Preparation method of high-purity magnolia bark total-phenol |
| 08/19/2009 | CN101507754A Traditional Chinese medicine preparation for treating coryza and preparation method thereof |
| 08/19/2009 | CN101507753A Medicine for treating rheumatism and manufacture method thereof |
| 08/19/2009 | CN101507739A Biological agent containing human ARMET protein or oligonucleotide active constituent and use thereof |
| 08/19/2009 | CN101507736A Traditional Chinese medicine preparation for treating senile dementia, ischium lumbar, swollen glands, get-wind or the other rheumatism |
| 08/19/2009 | CN100529759C Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 08/19/2009 | CN100529076C Mammalian cytokines, related reagents and methods |
| 08/19/2009 | CN100529074C Therapeutic binding molecules |
| 08/19/2009 | CN100528898C High purity ulinastatin and its prepn process and medicine composition |
| 08/19/2009 | CN100528884C Phosphor isoquinolinone, derivative, synthesis method and use thereof |
| 08/19/2009 | CN100528874C Pyrrolo [2,3d] pyrimidine compositions and their use |